Emerson A

MAPS Public Benefit Corporations, 1115 Mission St., Santa Cruz, CA, 95060, USA.

7 papers · 1 preprint

Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.

Jerome L, Feduccia AA, Wang JB +5

Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

Mithoefer MC, Feduccia AA, Jerome L +7

Effects of MDMA-assisted therapy for PTSD on self-experience.

van der Kolk BA, Wang JB, Yehuda R +7

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.

Feduccia AA, Jerome L, Yazar-Klosinski B +3

MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.

Mitchell JM, Bogenschutz M, Lilienstein A +35

Self-experience in MDMA assisted therapy of PTSD

van der Kolk BA, Wang JB, Yehuda R +7

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.

Wolfson PE, Andries J, Feduccia AA +10

History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).

Emerson A, Ponté L, Jerome L +1